<?xml version="1.0" encoding="UTF-8"?>
<p>Beginning in 2000, vaccines became integrated as key tools in helping developing nations achieve their MDGs and targets. Following the launch of the GAVI Alliance, many developing countries for the first time gained access to vaccines for combating rotavirus and 
 <italic>Haemophilus influenzae</italic> type b (Hib), and a new vaccine for pneumococcal vaccine was developed 
 <xref rid="pntd.0002808-Gavi1" ref-type="bibr">[39]</xref>, 
 <xref rid="pntd.0002808-Hotez10" ref-type="bibr">[40]</xref>. Partly because of these interventions, child mortality was reduced by almost one-half 
 <xref rid="pntd.0002808-Hotez10" ref-type="bibr">[40]</xref>. Included among these activities was GAVI's important work in providing vaccines for North Korea and other fragile states 
 <xref rid="pntd.0002808-Gavi2" ref-type="bibr">[41]</xref>.
</p>
